Stephen Biggar
Chairman
TScan Therapeutics, Inc. (TCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stephen Biggar
Stephen Biggar is recorded as Chairman at TScan Therapeutics, Inc. (TCRX). TScan Therapeutics, Inc. reported in an 8-K filed June 14, 2024 that Stephen Biggar was appointed Chairman of the Board, effective June 12, 2024.
“Current member of the Board, Stephen Biggar, M.D., Ph.D., assumed the role of Chairman of the Board, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-06-12–present
-
2021-01-01–2025-05-14
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TScan Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gavin MacBeath CEO, CFO
- Brian Silver CFO
- Jason A. Amello Chief Accounting Officer, Board Member
- Leiden Dworak Chief Accounting Officer
- Barbara Klencke, M.D. Board Member
- Chrystal Louis Board Member
- Garry A. Nicholson Board Member
- Katina Dorton Board Member
- R. Keith Woods Board Member
- Zoran Zdraveski Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.